2 days Abbott Laboratories: Long-Term Optimism, Short-Term OvervaluationSeeking Alpha Abbott Laboratories: Long-Term Optimism, Short-Term Overvaluation. Abbott Labs (ABT) X
2 days Penn Davis Mcfarland Inc. Makes New $3.62 Million Investment in Abbott Laboratories (NYSE:ABT)MarketBeat X
4 days Abbott Laboratories (ABT): Strong Q2 Performance and Innovative Product ApprovalsInsider Monkey X
5 days Buffington Mohr McNeal Has $8.37 Million Stock Position in Abbott Laboratories (NYSE:ABT)MarketBeat X
5 days Calls of the Day: Crowdstrike, Cheniere Energy, 3M, Abbott Labs, Abbvie and Eli LillyYouTube X
6 days Zacks Investment Ideas feature highlights: Abbott Laboratories, Equifax and SL Green RealtyZacks X
1 week Jim Cramer Says That FDA, NIH, and CDC Comments On Abbott Laboratories (ABT) Could Potential Help The Stock Going ForwardInsider Monkey X
2 weeks Abbott Laboratories (NYSE:ABT) Price Target Increased to $130.00 by Analysts at Royal Bank of CanadaMarketBeat X
2 weeks Abbott Laboratories started at Outperform by Oppenheimer on favorable risk/rewardInvesting.com X
3 weeks Abbott Laboratories (NYSE:ABT) Shares Sold by Northwestern Mutual Wealth Management Co.MarketBeat X
3 weeks Abbott Laboratories (ABT): 69 Hedge Fund Holders and Strong Wall Street SupportInsider Monkey X